AbbVie (ABBV) FCF Margin (QoQ) (2012 - 2026)
Powered by 
Analysis
AbbVie (ABBV) FCF Margin (QoQ) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - |
| 8 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn |
| 9 | United Therapeutics | 20.81 Bn | 18.15 Bn | 683.80 Mn |
| 10 | Jazz Pharmaceuticals | 16.02 Bn | 14.40 Bn | 1.09 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -543.00 |
| Mar 31, 2026 | -566.00 |
| Dec 31, 2025 | -1,269.00 |
| Sep 30, 2025 | 1,044.00 |
| Jun 30, 2025 | 2,117.00 |
| Mar 31, 2025 | -3,425.00 |
| Dec 31, 2024 | 879.00 |
| Sep 30, 2024 | 2,191.00 |
| Jun 30, 2024 | -1,721.00 |
| Mar 31, 2024 | -55.00 |
| Dec 31, 2023 | -2,101.00 |
| Sep 30, 2023 | 852.00 |
| Jun 30, 2023 | 1,142.00 |
| Mar 31, 2023 | -1,485.00 |
| Dec 31, 2022 | -241.00 |
| Sep 30, 2022 | 1,679.00 |
| Jun 30, 2022 | -172.00 |
| Mar 31, 2022 | 222.00 |
| Dec 31, 2021 | -2,098.00 |
| Sep 30, 2021 | 2,018.00 |